Transgenerational effects of maternal exposure to chemicals on the functional development of the brain in the offspring

Cancer Causes and Control

Volumn 8, Issue 3, 1997, Pages 524-528

  Fujii, Tomoko ^a,b  

^a TEIKYO UNIVERSITY   (Japan)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Maternal chemical exposure; Maternal drug exposure; Rat offspring behavior

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; ANXIOLYTIC AGENT; CHEMICAL AGENT; CHLORPROMAZINE; CISPLATIN; DNA; DOPAMINE; ETHOSUXIMIDE; GLUTAMATE RECEPTOR; GLUTAMATE SYNTHASE; GLUTAMIC ACID; HERBICIDE; IMIPRAMINE; KAINIC ACID; KAINIC ACID RECEPTOR; NEUROTRANSMITTER; NIMUSTINE; NORADRENALIN; PHOSPHINOTHRICIN; PSYCHOTROPIC AGENT; RNA; SEROTONIN; THALIDOMIDE; THYROXINE;

BRAIN; BRAIN DEVELOPMENT; BRAIN DYSFUNCTION; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; EPILEPSY; FEMALE; GESTATIONAL AGE; GROWTH ACCELERATION; HUMAN; HYPERTHERMIA; HYPOTHERMIA; MALE; NONHUMAN; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; REVIEW; RISK ASSESSMENT; WET DOG SHAKES;

AGGRESSION; AMINOBUTYRIC ACIDS; ANIMALS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTINEOPLASTIC AGENTS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; BRAIN; CHLORPROMAZINE; CISPLATIN; EMBRYONIC AND FETAL DEVELOPMENT; EMOTIONS; ENZYME INHIBITORS; ETHOSUXIMIDE; EXCITATORY AMINO ACID AGONISTS; FEMALE; FEVER; GESTATIONAL AGE; GLUTAMATE-AMMONIA LIGASE; HERBICIDES; HIPPOCAMPUS; HYPOTHERMIA; IMIPRAMINE; KAINIC ACID; MALE; MATERNAL EXPOSURE; NIMUSTINE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHOTROPIC DRUGS; RATS; RATS, INBRED STRAINS; RATS, WISTAR; RISK ASSESSMENT;

EID: 0030833871     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018477809755     Document Type: Review

References (22)

1. Martin JC, Martin DC, Radow B, Sigman G. Growth, development and activity in rat offspring following maternal drug exposure. Exper Aging Res 1976; 2: 235-51.
2. Fujii T, Adams PM, eds. Functional Teratogenesis: Functional Effects on the Offspring After Parental Drug Exposure. Tokyo, Japan: Teikyo University Press, 1987: 238.
3. Fujii T. Integrative assessment of the developmental pharmacology and developmental toxicology, with special reference to the brain. Folia pkarmacol japon 1991; 98: 419-34.
4. Chambers PL, Chambers CM, Bolt HM, Preziosi P, eds. Toxicology from Discovery and Experimentation to the Human Perspective. Amsterdam, The Netherlands: Elsevier, 1992: 800.
5. Jones KL, Smith DW, Ulleland CN, Streissguth AP. Pattern of malformation in offspring of chronic alcoholic mother. Lancet 1973; i: 1267-71.
6. Kellogg C, Tervo D, Ison J, Parisi T, Miller RK. Prenatal exposure to diazepam alters behavioral development in rats. Science 1979; 207: 205-7.
7. Gupta C, Jaffe SJ, Shapiro BH. Prenatal exposure to phenobarbital permanently decreases testosterone and causes reproductive dysfunction. Science 1982; 216: 640-2.
8. Fujii T, Ohtaki Y. Sex-related hyperthermic response to chlorpromazine in the offspring of rats treated with imipramine. Dev Pharmacol Ther 1985; 8: 364-73.
9. Lin MT, Chern YF, Chow CF, Li YP. Effects of brain serotonin alterations on hypothermia produced by chlorpromazine in rats. Pharmacology 1979; 18: 125-35.
10. Mirmiran M, Brenner E, VanDerGugten J, Swaab DF. Neurochemical and electrophysiological disturbances mediate developmental behavioral alterations produced by medicines. Neurobehav Toxicol Teratol 1985; 7: 677-83.
11. Nakanishi H, Fujii T. Behavioral changes in juvenile rats after prenatal exposure to ethosuximide. Pharmacol Biochem Behav 1990; 36: 163-8.
12. Nomura Y, Takère Y, Nomura Y, Shinagawa S, Kaneko S, Sato T. The physical and mental development of infants born to mothers treated with antiepileptic drugs. In: Sato S, Shinagawa S, eds. Antiepileptic Drugs and Pregnancy. Amsterdam, The Netherlands: Excerpta Medica, 1984: 187-95.
13. Fujii T, Hara N, Kuga Y. Maternal exposure of rats to sodium valproate develops tolerance to valproate itself in the offspring. Proc Japan Acad 1986; 62B: 140-3.
14. Wallace JA, Lauder JM. Development of serotonergic system in the rat embryo: An immunocytochemical study. Brain Res Bull 1983; 10: 459-79.
15. Coyle JT, Henry D. Catecholamines in fetal and newborn rat brain. J Neurochem 1973; 27: 61-7.
16. Fujii T, Kusama Y. Long-lasting effects on the brain of a single exposure to non-neuroactive compounds: Anticancer and immunosuppressive agents. In: Fujii T, Boer GJ, eds. Functional Neuroteratology of Short-term Exposure to Drugs. Tokyo, Japan: Teikyo University Press, 1991: 125-39.
17. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th Ed. Hardman TG, Limbird LB, eds. New York, NY (USA): MacGraw-Hill, 1996: 411.
18. Rodier RM. Chronology of neuron development: Animal studies and their clinical implications. Dev Med Child Neurol 1980; 22: 525-45.
19. Kaldor JM, Day NE, Hemminki K. Quantifying the carcinogenicity of antineoplastic drugs. Eur J Cancer Clin Oncol 1988; 24: 703-11.
20. Watanabe T. Chemicals and carcinogenicity. J Practical Pharmacy 1990; 41: 7-29.
21. Ebert E, Leist KH, Mayer D. Summary of safety evaluation toxicity studies of glufosinate ammonium. Fd Chem Toxic 1990; 28: 339-49.
22. Fujii T. Biochemical and pharmacological assessment of transgenerational and latent functional disorders induced by man-made toxic agents. 1994 Report of Comprehensive Research on the Human and Earth, in Aid of Ministry of Education, Science, Sports and Culture. Tokyo, Japan, 1994: 286-8.